Back to Wealth Enhancement Advisory Services, LLC Wealth Enhancement Advisory Services, LLC

CVS

30 quarters

Position history for Wealth Enhancement Advisory Services, LLCWealth Enhancement Advisory Services, LLC's holdings in CVS Health Corporation

Yes. Wealth Enhancement Advisory Services holds 495,488 shares of CVS (CVS Health), worth $40.6M, as of its Q3 2026 13F filing. It increased the position by 67,143 shares (+15.7%) from Q2 2026. Wealth Enhancement Advisory Services has held CVS since Q3 2021, across 21 quarterly 13F filings. CVS is 0.1% of Wealth Enhancement Advisory Services' reported 13F portfolio.

Current Value

$40.6M

Current Shares

495,488

Total Value Change

+$39.7M

Total Shares Change

+477,047

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
495,488
+15.7%
$40.6M0.1%$85.08
34
2026-Q2
Increased
428,345
+16.7%
$41.8M0.1%$102.08
34
2026-Q1
Decreased
367,097
-15.8%
$25.1M0.1%$70.25
0
2025-Q4
Increased
436,076
+10.0%
$35.2M0.0%$77.00
32
2025-Q3
Increased
396,368
+186.6%
$30.6M0.0%$72.55
46
2025-Q2
Decreased
138,318
-7.3%
$9.3M0.0%$65.67
0
2025-Q1
Decreased
149,247
-48.0%
$10.1M0.0%$63.84
0
2024-Q4
Increased
286,990
+67.5%
$12.9M0.0%$41.77
41
2024-Q3
Decreased
171,387
-6.7%
$10.8M0.0%$57.86
0
2024-Q2
Decreased
183,720
-9.4%
$10.9M0.0%$53.74
0
2024-Q1
Increased
202,838
+0.4%
$16.2M0.0%$71.88
28
2023-Q4
Decreased
202,015
-65.6%
$16M0.0%$70.52
0
2023-Q3
Increased
586,815
+6506.1%
$41M0.1%$61.82
56
2023-Q2
Decreased
8,883
-42.4%
$614,0830.0%$60.71
0
2023-Q1
Increased
15,423
+225.1%
$1.1M0.0%$64.73
41
2022-Q4
Decreased
4,744
-3.5%
$412,9870.0%$80.62
0
2022-Q3
Decreased
4,915
-91.3%
$434,0000.0%$82.01
0
2022-Q2
Increased
56,542
+604.2%
$5.3M0.1%$79.22
44
2022-Q1
Increased
8,029
+0.3%
$803,0000.0%$86.08
25
2021-Q4
Decreased
8,002
-52.3%
$853,0000.0%$87.28
0
2021-Q3
New
16,786
-
$1.5M0.0%$71.38
35
2021-Q2
Exited
0
-100.0%
$00.0%$69.76
0
2021-Q1
Increased
17,129
+1.5%
$1.3M0.0%$62.49
26
2020-Q4
Decreased
16,871
-39.4%
$1.3M0.0%$56.36
0
2020-Q3
New
27,847
-
$1.7M0.0%$47.78
36
2020-Q1
Exited
0
-100.0%
$00.0%$47.77
0
2019-Q4
Increased
22,570
+22.2%
$1.7M0.1%$59.41
31
2019-Q3
Decreased
18,473
-66.5%
$1.2M0.0%$50.06
0
2019-Q2
Increased
55,200
+199.3%
$3.1M0.1%$42.86
51
2019-Q1
First report
18,441
-
$977,0000.1%$42.02
0

Other major holders of CVS: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used